About ESPERER
ESPERER is a company based in Mumbai (India) founded in 2018 by Raktim Chattopadhyay. The company has 12 employees as of March 31, 2024.
- Headquarter Mumbai, India
- Employees 12 as on 31 Mar, 2024
- Founders Raktim Chattopadhyay
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Esperer Bio-Research Private Limited
- Date of Incorporation 16 Aug, 2018
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$277.64 K (USD)-57.26as on Mar 31, 2023
-
Net Profit
-$495.03 K (USD)-502.02as on Mar 31, 2023
-
EBITDA
-$502.33 K (USD)-393.71as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
12
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ESPERER
Investors in ESPERER
ESPERER has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Zenfold.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and venture building in high-growth areas, focusing on incubation and strategic partnerships.
|
Locked | Locked | Locked |
Investor details for ESPERER
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ESPERER
Investment portfolio details for ESPERER
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ESPERER
Detailed financials for ESPERER
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Esperer Comparisons
Peer comparison for ESPERER
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ESPERER
Detailed competitors of ESPERER
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Esperer
Complete news archive for ESPERER
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ESPERER
ESPERER was founded in 2018 and raised its 1st funding round 2 years after it was founded.
ESPERER is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Raktim Chattopadhyay is the current CEO of ESPERER. They have also founded this company.
As of Mar 31, 2024, the latest employee count at ESPERER is 12.
Annual revenue of ESPERER is $277.64K as on Mar 31, 2023.
Esperer was founded in 2018 and is headquartered in Mumbai, India. Oncology drugs are produced by the company within the pharmaceutical sector, with operations centered on bioresearch and development. Focus is placed on cancer-related treatments, supported by a team led by founder and CEO Raktim Chattopadhyay. Activities are conducted primarily in India, targeting the oncology market through manufacturing processes.
ESPERER has 1 investor. Key investors include Zenfold.